History | Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis | Guidance | NICE

History

Review proposal consultation

Review proposal consultation
Stakeholder matrix (PDF 40 KB)

Published:

02 August 2016
Review proposal paper (PDF 290 KB)

Published:

13 September 2016

Background information

Psoriatic arthritis - etanercept, infliximab and adalimumab: review proposal - June 2013 information
Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix A matrix of stakeholders (PDF 40 KB)

Published:

13 June 2013
Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive (PDF 468 KB)

Published:

13 June 2013
Psoriatic arthritis - etanercept, infliximab and adalimumab: press release information
2010/120 NICE improves access to drug treatments for psoriatic arthritis (PDF 60 KB)

Published:

06 December 2013

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final appraisal determination

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final appraisal determination information
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final appraisal determination (PDF 227 KB)

Published:

11 June 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): response to consultee, commentator and public comments on the ACD (PDF 138 KB)

Published:

11 June 2010
Consultee and commentator comments on the ACD
Abbott response to PsA ACD (PDF 15 KB)

Published:

11 June 2010
Pfizer Enbrel response to PsA ACD (PDF 14 KB)

Published:

11 June 2010
Pfizer Enbrel pooled estimates of PASI response (PDF 15 KB)

Published:

11 June 2010
Schering Plough response to PsA ACD (PDF 139 KB)

Published:

11 June 2010
The Psoriasis and Psoriatic Arthritis Alliance response to PsA ACD (PDF 72 KB)

Published:

11 June 2010
Royal College of Nursing response to PsA ACD (PDF 22 KB)

Published:

11 June 2010
Department of Health response to PsA ACD (PDF 10 KB)

Published:

11 June 2010
NHS Quality Improvement Scotland response to PsA ACD (PDF 19 KB)

Published:

11 June 2010
Welsh Assembly Government response to PsA ACD (PDF 8.9 KB)

Published:

11 June 2010
York Assessment Group response to PsA ACD (PDF 16 KB)

Published:

11 June 2010
Expert comments on the ACD
Dr Eleanor Korendowych (PDF 8.2 KB)

Published:

11 June 2010
Dr Philip Helliwell (PDF 8.2 KB)

Published:

11 June 2010
Revisions to the cost effectiveness analysis after the committee meeting of 16 February 2010 (PDF 50 KB)

Published:

16 June 2010
Revisions to the cost effectiveness analysis following comments from consultees on 2 February 2010 (PDF 288 KB)

Published:

16 June 2010

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document information
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: evaluation report
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: overview (PDF 257 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: assessment report
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: assessment report (PDF 2.65 MB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: additional analyses following committee meeting (PDF 26 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: appendix 10.13 (PDF 46 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: responses to consultees' comments (PDF 150 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Abbott AR (PDF 188 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Abbott EM (PDF 31 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - British Association of Dermatologists (PDF 8.9 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - British Society for Rheumatology (PDF 94 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Hull Teaching PCT (PDF 34 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Schering Plough (PDF 185 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Welsh Assembly Government (PDF 7.7 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report - Wyeth (PDF 26 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: non-manufacturer submission
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: non-manufacturer submission - Royal College of Physicians (PDF 7.8 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: non-manufacturer submission - British Society for Rheumatology (PDF 87 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: non-manufacturer submission - British Association of Dermatologists (PDF 24 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: manufacturer submissions
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: manufacturer submissions - Abbott (PDF 34 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: manufacturer submissions - Schering Plough (PDF 40 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: manufacturer submissions - Wyeth (PDF 130 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: expert written personal statements
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: expert written personal statements - Helliwell (PDF 32 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: expert written personal statements - Korendowych (PDF 22 KB)

Published:

15 March 2010
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: expert written personal statements - Morris (PDF 15 KB)

Published:

15 March 2010

Psoriatic arthritis - etanercept, infliximab and adalimumab: Final Assessment Report

Psoriatic arthritis - etanercept, infliximab and adalimumab: Final Assessment Report (PDF 2.64 MB)

Published:

22 December 2009

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final protocol

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final protocol (PDF 89 KB)

Published:

21 July 2009

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): Consultee and commentator comments on the draft scope, and the Institute's response

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): Consultee and commentator comments on the draft scope, and the Institute's response (PDF 29 KB)

Published:

18 May 2009

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): Final matrix of consultees and commentators

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): final scope (PDF 52 KB)

Published:

18 May 2009

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): final scope

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): final scope (PDF 52 KB)

Published:

18 May 2009

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): draft scope

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): draft scope (PDF 55 KB)

Published:

31 March 2009

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): provisional matrix of consultees and commentators

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): provisional matrix of consultees and commentators (PDF 34 KB)

Published:

31 March 2009

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): update on scope

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): update on scope (PDF 11 KB)

Published:

14 November 2008

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): draft scope

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): draft scope (PDF 38 KB)

Published:

16 May 2008

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): provisional matrix

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): provisional matrix (PDF 46 KB)

Published:

16 May 2008